Task: Answer the multiple choice question.
Question: Which compound exhibits a -4.019% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COc1ccccc1C1C(C#N)=C(N)Oc2c1c(-c1ccccc1)nn2-c1ccccc1
b. CN1CCN(C(=O)/C(=C\c2cccnc2)NC(=O)c2cccc(Br)c2)CC1
Answer: b. CN1CCN(C(=O)/C(=C\c2cccnc2)NC(=O)c2cccc(Br)c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(C(=O)/C(=C\c2cccnc2)NC(=O)c2cccc(Br)c2)CC1
CN1CCN(C(=O)/C(=C\c2cccnc2)NC(=O)c2cccc(Br)c2)CC1
3-bromo-N-[(E)-3-(4-methylpiperazin-1-yl)-3-oxo-1-pyridin-3-ylprop-1-en-2-yl]benzamide